Clinical Trial: Determination of the Median Effective Dose (ED50) of Tegileridine Fumarate for Inhibiting Responses to Endotracheal Intubation during Target-Controlled Infusion of Propofol (China)

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Determination of the Median Effective Dose (ED50) of Tegileridine Fumarate for Inhibiting Responses to Endotracheal Intubation during Target-Controlled Infusion of Propofol'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134492

Registration Time: 2026/10/15

Type: Interventional study

Primary Sponsor: Shanghai Minhang District centeral hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341916

Published by HT Digital Content Services with permission from Health Daily Digest....